Selected research
Industry Growth & Trends
Global Airsickness Treatment Industry Growth and Trends Forecast to 2032
Market perspective
The global Airsickness Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Airsickness Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Airsickness Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Airsickness Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Airsickness Treatment include Caleb Pharmaceuticals, Myungmoon Pharm, Prestige Brands, WellSpring Pharmaceutical Corporation, Baxter International, GlaxoSmithKline, Pfizer, Mylan and Sandoz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Airsickness Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Airsickness Treatment market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Airsickness Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Airsickness Treatment.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Airsickness Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Airsickness Treatment Market by Company
Caleb Pharmaceuticals
Myungmoon Pharm
Prestige Brands
WellSpring Pharmaceutical Corporation
Baxter International
GlaxoSmithKline
Pfizer
Mylan
Sandoz
Airsickness Treatment Segment by Type
Anticholinergic
Antihistamines
Others
Airsickness Treatment Segment by Application
Adults
Children
Airsickness Treatment Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Airsickness Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Airsickness Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Airsickness Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Airsickness Treatment manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Airsickness Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Anticholinergic
- Antihistamines
- Others
Applications
- Adults
- Children
Companies covered
- Caleb Pharmaceuticals
- Myungmoon Pharm
- Prestige Brands
- WellSpring Pharmaceutical Corporation
- Baxter International
- GlaxoSmithKline
- Pfizer
- Mylan
- Sandoz
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Airsickness Treatment Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Airsickness Treatment Sales Estimates and Forecasts (2021-2032)
- 1.3 Airsickness Treatment Market by Type
- 1.3.1 Anticholinergic
- 1.3.2 Antihistamines
- 1.3.3 Others
- 1.4 Global Airsickness Treatment Market Size by Type
- 1.4.1 Global Airsickness Treatment Market Size Overview by Type (2021-2032)
- 1.4.2 Global Airsickness Treatment Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Airsickness Treatment Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Airsickness Treatment Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Airsickness Treatment Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Airsickness Treatment Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Airsickness Treatment Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Airsickness Treatment Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Airsickness Treatment Industry Trends
- 2.2 Airsickness Treatment Industry Drivers
- 2.3 Airsickness Treatment Industry Opportunities and Challenges
- 2.4 Airsickness Treatment Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Airsickness Treatment Revenue (2021-2026)
- 3.2 Global Top Players by Airsickness Treatment Sales (2021-2026)
- 3.3 Global Top Players by Airsickness Treatment Price (2021-2026)
- 3.4 Global Airsickness Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Airsickness Treatment Major Company Production Sites & Headquarters
- 3.6 Global Airsickness Treatment Company, Product Type & Application
- 3.7 Global Airsickness Treatment Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Airsickness Treatment Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Airsickness Treatment Players Market Share by Revenue in 2025
- 3.8.3 2025 Airsickness Treatment Tier 1, Tier 2, and Tier 3
4 Airsickness Treatment Regional Status and Outlook
- 4.1 Global Airsickness Treatment Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Airsickness Treatment Historic Market Size by Region
- 4.2.1 Global Airsickness Treatment Sales in Volume by Region (2021-2026)
- 4.2.2 Global Airsickness Treatment Sales in Value by Region (2021-2026)
- 4.2.3 Global Airsickness Treatment Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Airsickness Treatment Forecasted Market Size by Region
- 4.3.1 Global Airsickness Treatment Sales in Volume by Region (2027-2032)
- 4.3.2 Global Airsickness Treatment Sales in Value by Region (2027-2032)
- 4.3.3 Global Airsickness Treatment Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Airsickness Treatment by Application
- 5.1 Airsickness Treatment Market by Application
- 5.1.1 Adults
- 5.1.2 Children
- 5.2 Global Airsickness Treatment Market Size by Application
- 5.2.1 Global Airsickness Treatment Market Size Overview by Application (2021-2032)
- 5.2.2 Global Airsickness Treatment Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Airsickness Treatment Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Airsickness Treatment Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Airsickness Treatment Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Airsickness Treatment Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Airsickness Treatment Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Airsickness Treatment Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Caleb Pharmaceuticals
- 6.1.1 Caleb Pharmaceuticals Company Information
- 6.1.2 Caleb Pharmaceuticals Business Overview
- 6.1.3 Caleb Pharmaceuticals Airsickness Treatment Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Caleb Pharmaceuticals Airsickness Treatment Product Portfolio
- 6.1.5 Caleb Pharmaceuticals Recent Developments
- 6.2 Myungmoon Pharm
- 6.2.1 Myungmoon Pharm Company Information
- 6.2.2 Myungmoon Pharm Business Overview
- 6.2.3 Myungmoon Pharm Airsickness Treatment Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Myungmoon Pharm Airsickness Treatment Product Portfolio
- 6.2.5 Myungmoon Pharm Recent Developments
- 6.3 Prestige Brands
- 6.3.1 Prestige Brands Company Information
- 6.3.2 Prestige Brands Business Overview
- 6.3.3 Prestige Brands Airsickness Treatment Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Prestige Brands Airsickness Treatment Product Portfolio
- 6.3.5 Prestige Brands Recent Developments
- 6.4 WellSpring Pharmaceutical Corporation
- 6.4.1 WellSpring Pharmaceutical Corporation Company Information
- 6.4.2 WellSpring Pharmaceutical Corporation Business Overview
- 6.4.3 WellSpring Pharmaceutical Corporation Airsickness Treatment Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 WellSpring Pharmaceutical Corporation Airsickness Treatment Product Portfolio
- 6.4.5 WellSpring Pharmaceutical Corporation Recent Developments
- 6.5 Baxter International
- 6.5.1 Baxter International Company Information
- 6.5.2 Baxter International Business Overview
- 6.5.3 Baxter International Airsickness Treatment Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Baxter International Airsickness Treatment Product Portfolio
- 6.5.5 Baxter International Recent Developments
- 6.6 GlaxoSmithKline
- 6.6.1 GlaxoSmithKline Company Information
- 6.6.2 GlaxoSmithKline Business Overview
- 6.6.3 GlaxoSmithKline Airsickness Treatment Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 GlaxoSmithKline Airsickness Treatment Product Portfolio
- 6.6.5 GlaxoSmithKline Recent Developments
- 6.7 Pfizer
- 6.7.1 Pfizer Company Information
- 6.7.2 Pfizer Business Overview
- 6.7.3 Pfizer Airsickness Treatment Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Pfizer Airsickness Treatment Product Portfolio
- 6.7.5 Pfizer Recent Developments
- 6.8 Mylan
- 6.8.1 Mylan Company Information
- 6.8.2 Mylan Business Overview
- 6.8.3 Mylan Airsickness Treatment Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Mylan Airsickness Treatment Product Portfolio
- 6.8.5 Mylan Recent Developments
- 6.9 Sandoz
- 6.9.1 Sandoz Company Information
- 6.9.2 Sandoz Business Overview
- 6.9.3 Sandoz Airsickness Treatment Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Sandoz Airsickness Treatment Product Portfolio
- 6.9.5 Sandoz Recent Developments
7 North America by Country
- 7.1 North America Airsickness Treatment Sales by Country
- 7.1.1 North America Airsickness Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Airsickness Treatment Sales by Country (2021-2026)
- 7.1.3 North America Airsickness Treatment Sales Forecast by Country (2027-2032)
- 7.2 North America Airsickness Treatment Market Size by Country
- 7.2.1 North America Airsickness Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Airsickness Treatment Market Size by Country (2021-2026)
- 7.2.3 North America Airsickness Treatment Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Airsickness Treatment Sales by Country
- 8.1.1 Europe Airsickness Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Airsickness Treatment Sales by Country (2021-2026)
- 8.1.3 Europe Airsickness Treatment Sales Forecast by Country (2027-2032)
- 8.2 Europe Airsickness Treatment Market Size by Country
- 8.2.1 Europe Airsickness Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Airsickness Treatment Market Size by Country (2021-2026)
- 8.2.3 Europe Airsickness Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Airsickness Treatment Sales by Country
- 9.1.1 Asia-Pacific Airsickness Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Airsickness Treatment Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Airsickness Treatment Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Airsickness Treatment Market Size by Country
- 9.2.1 Asia-Pacific Airsickness Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Airsickness Treatment Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Airsickness Treatment Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Airsickness Treatment Sales by Country
- 10.1.1 South America Airsickness Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Airsickness Treatment Sales by Country (2021-2026)
- 10.1.3 South America Airsickness Treatment Sales Forecast by Country (2027-2032)
- 10.2 South America Airsickness Treatment Market Size by Country
- 10.2.1 South America Airsickness Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Airsickness Treatment Market Size by Country (2021-2026)
- 10.2.3 South America Airsickness Treatment Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Airsickness Treatment Sales by Country
- 11.1.1 Middle East and Africa Airsickness Treatment Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Airsickness Treatment Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Airsickness Treatment Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Airsickness Treatment Market Size by Country
- 11.2.1 Middle East and Africa Airsickness Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Airsickness Treatment Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Airsickness Treatment Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Airsickness Treatment Value Chain Analysis
- 12.1.1 Airsickness Treatment Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Airsickness Treatment Production Mode & Process
- 12.2 Airsickness Treatment Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Airsickness Treatment Distributors
- 12.2.3 Airsickness Treatment Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst